Merck News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

29.12.20	Biotech Stocks Facing FDA Decision In January 2021 (RTTNews)
28.12.20	AstraZeneca : Japan Approves Lynparza To Treat Three Types Of Advanced Cancer (RTTNews)
23.12.20	Merck Collaborates With U.S. Government To Advance Investigational Biological Therapy For COVID-19 (RTTNews)
17.12.20	Merck: FDA Grants Priority Review To SBLA For Keytruda Plus Chemotherapy (RTTNews)
16.12.20	Merck : Keytruda Plus Lenvima Meets Primary Goal In Phase 3 Trial On Advanced Endometrial Cancer (RTTNews)
11.12.20	Merck Reports Positive CHMP Opinion For KEYTRUDA - Quick Facts (RTTNews)
10.12.20	Coalition Of CEOs Pledge 1 Mln Jobs For Black Americans (RTTNews)
02.12.20	Merck Sells Direct Holding In Moderna - Quick Facts (RTTNews)
27.11.20	European Medicines Agency Validates Application for Tepotinib for the Treatment of Advanced NSCLC with METex14 Skipping Alterations (PR Newswire)
24.11.20	AZN's COVID Shot 70% Effective On Average, ARQT Aces Scalp Psoriasis Study, BLRX' BLAST Fizzles (RTTNews)
23.11.20	Merck To Buy OncoImmune; Submits Applications For 15-valent Pneumococcal Conjugate Vaccine (RTTNews)
16.11.20	Merck: Bill & Melinda Foundation To Support Islatravir Phase 3 Trial - Quick Facts (RTTNews)
09.11.20	Merck Announces Out-Licensing Agreement for Investigational Atacicept with Vera Therapeutics (PR Newswire)
06.11.20	Pre-market Movers In Healthcare Sector: RGLS, ASMB, GBT, ONCT… (RTTNews)
05.11.20	Pappas Capital's VelosBio To Be Acquired By Merck In $2.75 Bln Cash Deal (RTTNews)
27.10.20	Merck Updates FY20 Guidance; Q3 Profit Tops Estimates - Quick Facts (RTTNews)
26.10.20	Biotech Stocks Facing FDA Decision In November 2020 (RTTNews)
20.10.20	Merck Reports Positive Data From 2 Trials Of V114 Pneumococcal Conjugate Vaccine (RTTNews)
15.10.20	Merck's KEYTRUDA Approved By Health Canada As First-line Treatment In Metastatic Recurrent HNSCC (RTTNews)
08.10.20	Merck Mid-stage HIV Study On Islatravir- Doravirine Shows Viral Suppression Maintained (RTTNews)
08.10.20	Moderna Regains Rights To Respiratory Syncytial Virus Vaccine From Merck - Quick Facts (RTTNews)
06.10.20	Merck Announces Out-Licensing Agreement for Phase II-ready Anti-ADAMTS5 Nanobody for Osteoarthritis (PR Newswire)
29.09.20	Celyad Collaborates With Merck To Evaluate CYAD-101 With KEYTRUDA On Microsatellite Stable MCRC (RTTNews)
26.09.20	Biotech Stocks Facing FDA Decision In October 2020 (RTTNews)
21.09.20	AstraZeneca: Lynparza Recommended For Approval In EU For Prostate Cancer, Ovarian Cancer (RTTNews)
18.09.20	AstraZeneca: LYNPARZA Shows Progression-free Survival Benefit In Five-year Follow-up Data (RTTNews)
17.09.20	Vaccinex In Clinical Collaboration Deal With Merck To Evaluate Pepinemab And KEYTRUDA (RTTNews)
15.09.20	Merck: Health Canada Approves BRENZYS For Four New Indications (RTTNews)
15.09.20	MRNS Catches Eye, SAVA Soars On Alzheimer's Study, ETNB Abuzz Over NASH Trial, GILD Snaps Up IMMU (RTTNews)
14.09.20	Seattle Genetics, Merck Announce Two New Strategic Oncology Collaborations - Quick Facts (RTTNews)
14.09.20	Merck Advances Oncology Portfolio and Pipeline with New and Long-term Data in Multiple Cancers at ESMO 2020 (PR Newswire)
11.09.20	New MAVENCLAD® Data at ACTRIMS-ECTRIMS MSVirtual2020 Meeting Highlight Rapid Onset of Action and Compelling Post-Approval Safety (PR Newswire)
10.09.20	Merck Announces Positive Phase II Results for Investigational Sonelokinab (M1095) in Patients with Moderate to Severe Chronic Plaque-Type Psoriasis (PR Newswire)
09.09.20	Merck Reports Positive Topline Results From Two Adult Studies Evaluating V114 (RTTNews)
08.09.20	Merck: Gefapixant Significantly Reduced Cough Frequency Compared To Placebo In Two Phase 3 Trials (RTTNews)
03.09.20	Merck to Showcase New Data at ACTRIMS-ECTRIMS MSVirtual2020 Meeting, Furthering Innovation in Multiple Sclerosis (PR Newswire)
02.09.20	Merck To Present New Data From Oncology Development Program At ESMO Virtual Congress (RTTNews)
02.09.20	Highlight, Merck Partner To To Evaluate Combination Of BO-112 And KEYTRUDA (RTTNews)
20.08.20	JNJ Acquires MNTA, FDA Strikes Down BMRN's Gene Therapy, BLRX's GENESIS On Track, TPTX On Watch (RTTNews)
19.08.20	Merck : Phase 3 Study Of KEYTRUDA - Chemotherapy On Metastatic Esophageal Cancer Meets Main Goal (RTTNews)
31.07.20	Merck Q2 Results Top Estimates; Boosts FY20 Outlook (RTTNews)
31.07.20	Merck & Co Inc. Q2 adjusted earnings Beat Estimates (RTTNews)
17.07.20	ACIU'S Alzheimer's Vaccine Study Chugs Along, LCI Up On Distribution Deal, TLSA Hits New High (RTTNews)
16.07.20	FDA Accepts Merck's NDA For Vericiguat For Priority Review - Quick Facts (RTTNews)
10.07.20	Botox, Keytruda Get FDA Approval For New Uses, BVXV Abuzz, First Droopy Eyelid Treatment Is Here (RTTNews)
08.07.20	FDA Issues CRL To Merck, Eisai For Keytruda Plus Lenvima Combination - Quick Facts (RTTNews)
08.07.20	Foghorn Therapeutics, Merck Enter Strategic Collaboration - Quick Facts (RTTNews)
08.07.20	AstraZeneca: Lynparza Gets EU Approval For BRCA-mutated Metastatic Pancreatic Cancer (RTTNews)
06.07.20	Merck: New Analyses Show Additional Efficacy Data For Islatravir, Doravirine Combination (RTTNews)
06.07.20	Ascentage, Merck To Evaluate APG-115 In Combination With KEYTRUDA In Advanced Solid Tumors (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

19.11.24		Schwacher Handel: Dow Jones beendet den Dienstagshandel mit Verlusten
19.11.24		Gute Stimmung in New York: NASDAQ 100 letztendlich im Plus
19.11.24		Schwacher Handel: Dow Jones legt am Dienstagnachmittag den Rückwärtsgang ein
19.11.24		Gewinne in New York: NASDAQ 100 legt zu
19.11.24		Dow Jones-Handel aktuell: So entwickelt sich der Dow Jones aktuell
19.11.24		Schwache Performance in Europa: Euro STOXX 50 zeigt sich zum Handelsende schwächer
19.11.24		Angespannte Stimmung in Europa: STOXX 50 verliert schlussendlich

19.11.24

Schwacher Handel: Dow Jones beendet den Dienstagshandel mit Verlusten

19.11.24

Gute Stimmung in New York: NASDAQ 100 letztendlich im Plus

19.11.24

Schwacher Handel: Dow Jones legt am Dienstagnachmittag den Rückwärtsgang ein

19.11.24

Gewinne in New York: NASDAQ 100 legt zu

19.11.24

Dow Jones-Handel aktuell: So entwickelt sich der Dow Jones aktuell

19.11.24

Schwache Performance in Europa: Euro STOXX 50 zeigt sich zum Handelsende schwächer

19.11.24

Angespannte Stimmung in Europa: STOXX 50 verliert schlussendlich

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Givaudan	3’870.00	1.49 %	K V
Lonza Grp	513.60	1.14 %	K V
Swiss Re	125.25	0.20 %	K V
Holcim	88.46	0.11 %	K V
Kuehne+Nagel Int	210.40	0.00 %	K V
Logitech Intl	68.92	-1.20 %	K V
Part Grp Hldg	1’209.00	-1.47 %	K V
CieFinRichemont	118.90	-1.94 %	K V
Nestle	76.66	-1.94 %	K V
Sonova Hldg	300.40	-5.21 %	K V

Nachrichten zu Merck Co.

Aktien Top/Flop

Merck Peer Group Nachrichten

Meistgelesene Nachrichten